Nicholas Montemurro, MD
Sports Medicine · Massapequa, NYNPI 1518311729
Payments from drug & device makers
What this record shows
This record is dominated by grants: $25,984 of the $39,328 with a category attached, or 66.1%. Arthrex accounts for 63.1% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2021 at $27,384 and has fallen 93.2% since, to $1,856 in 2025.
Across 119 payments — averaging $330.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$25K
- Smith+Nephew$4K
- Medical Device Business Services, Inc.$4K
- DJO, LLC$3K
- Stryker$2K
- Polaris Technology Solutions LLC$610
- plus $1K from 7 others
What the payments were for
- Grants$25,98466%
- Travel & lodging$3,5839%
- Food & beverage$5,74515%
- Education$4,01710%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 58 | $24,821 |
| Smith+Nephew | 4 | $4,003 |
| Medical Device Business Services, Inc. | 2 | $3,834 |
| DJO, LLC | 4 | $2,500 |
| Stryker | 25 | $2,371 |
| Polaris Technology Solutions LLC | 10 | $610 |
| Johnson & Johnson | 6 | $597 |
| Zimmer Biomet | 4 | $322 |
| Gotham Surgical Solutions & Devices, Inc. | 1 | $99 |
| Heraeus Medical, LLC. | 1 | $82 |
| Acumed LLC | 2 | $40 |
| Ferring Pharmaceuticals Inc. | 1 | $25 |
| Bioventus LLC | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$785
- NA$573
- VARIAX$260
- GAMMA$260
- Bone Anchors with Arthroscopic Delivery System$181
- PICO7$156
- ACTIS$147
- AUGMENT INJECTABLE$139
- AXSOS$139
- HOFFMANN$139
- mymobility Platform$132
- EXPert Nail$124
- PANGEA$122
How this compares
$39,328 in reported general payments places this provider in the 85th percentile of 403 sports medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 62 | $166 |
| Diclofenac Sodium | 12 | $44 |
| Oxycodone Hcl | 11 | $28 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Massapequa
- Steven LeeNyc$3.3M
- James PaciWoodbury$2.1M
- Gregory DifeliceNew York$1.8M
- Ilya VoloshinRochester$786K
- Theodore BlaineNew York$765K
- Robert MeislinNew York$720K
- Danyal NawabiNew York$592K
- Stephen NicholasNyc$586K
- Riley WilliamsNew York$512K
- Bryan KellyNew York$409K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.